Strategic Overview

PHC is a Japanese diagnostics company developing automated detection systems for TB treatment monitoring.

Innovation Portfolio

PATHFAST TB LAM Ag
Category: MONITORING Stage: Commercial

A high-sensitivity quantitative assay for measuring Lipoarabinomannan (LAM) in human sputum. Leveraging MAGTRATION® technology, it provides a precise 'bacterial load' equivalent that correlates with smear scores and culture positivity, making it an ideal tool for TB treatment monitoring.

Bacterial Load Sputum

Key Milestones

PATHFAST TB LAM Ag automated detection test
88.8% sensitivity, 100% specificity
47-minute turnaround
Commercial availability
Primary-level capability
Sputum-based testing